Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody.
- DOI
- 10.1016/j.intimp.2024.113102
- Published
- 2024 Dec 5
- Container
- International immunopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2024.113102,
title = {Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody.},
author = {Wang X and Kong Y and Qiu T and Chen T and Liu Y and Shi G and Sun Q and Chen W and Zhang J and Qiu J},
year = {2024},
journal = {International immunopharmacology},
doi = {10.1016/j.intimp.2024.113102},
url = {https://doi.org/10.1016/j.intimp.2024.113102}
}RIS
TY - JOUR TI - Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody. AU - Wang X AU - Kong Y AU - Qiu T AU - Chen T AU - Liu Y AU - Shi G AU - Sun Q AU - Chen W AU - Zhang J AU - Qiu J PY - 2024 JO - International immunopharmacology DO - 10.1016/j.intimp.2024.113102 UR - https://doi.org/10.1016/j.intimp.2024.113102 ER -
APA
X, W., Y, K., T, Q., T, C., Y, L., G, S., Q, S., W, C., J, Z., & J, Q. (2024). Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113102
Source records
- pubmed · retrieved 2026-09-27T11:23:44.622Z